It is a pharma private limited company based in Payyanur, Kerala, India, established in 2013.
2013 | Payyanur, Kerala, India | ActiveMedan Pharmaceuticals Private Limited, a active private limited company, was established on 18 November 2013 in Payyanur, Kerala, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U52100KL2013PTC035434. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹3.10 M and a paid-up capital of ₹3.10 M.
It upholds a compliant status. Employing 15 professional, Its leadership includes Kalla Veedu Nidhin (Director), Deepa Pattuvanmar Veetil (Managing Director), Vipin Pattuvanmar Veedu (Director). Past directors included Deepa Pattuvanmar Veetil, Rajesh Raghavan. It holds ₹7.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Raghavbhavan,Pmc-20/301-1Oppositenewbusstandplot,Mavicherry, Payyanur, Kerala, 670307.
U52100KL2013PTC035434
035434
18 November 2013
₹3.10 M
₹3.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Medan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalla Veedu Nidhin | Director | 26 Oct 2022 | Current |
| Deepa Pattuvanmar Veetil | Managing Director | 18 Nov 2013 | Current |
| Vipin Pattuvanmar Veedu | Director | 26 Oct 2022 | Current |
| Arjun Thekadavan | Director | 26 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Nov 2022 | Past |
| Pramod Abcsdd | Director | 14 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.01% increase. The company also saw a substantial improvement in profitability, with a 124.74% increase in profit. The company's net worth moved up by a moderate rise of 1.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2022 | Others | ₹4.50 M | Open |
| 16 Feb 2016 | Punjab National Bank | ₹2.70 M | Open |
Explore comprehensive loan charge details -
Medan Pharmaceuticals has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Medan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
The activity A charge with Others of Rs. 4.50 M registered on 18 Mar 2022 with Charge ID 100572711 was modified on 14 Mar 2024. was completed.
Progress on Kalla Veedu Nidhin was appointed as a Director was appointed as a Director on 26 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
Vipin Pattuvanmar Veedu was appointed as a Director was appointed as a Director on 26 Oct 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
Progress on Arjun Thekadavan was appointed as a Director was appointed as a Director on 26 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
The CIN of Medan Pharmaceuticals Private Limited is U52100KL2013PTC035434.
Medan Pharmaceuticals Private Limited is headquartered at Raghavbhavan,Pmc-20/301-1Oppositenewbusstandplot,Mavicherry, Payyanur, Kerala, 670307.
Medan Pharmaceuticals Private Limited was incorporated on 18 November 2013.
The current directors of Medan Pharmaceuticals Private Limited are
The primary industry of Medan Pharmaceuticals Private Limited is Trade.
Medan Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medan Pharmaceuticals Private Limited is ₹3.10 M, and the paid-up capital is ₹3.10 M.
The compliance status of Medan Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX